Torrent Pharma to launch Molnupiravir under the brand name Molnutor® in India

Tuesday December 28, 2021 at 3:49 pm

Torrent Pharma has today announced that it is introducing MSD (a trade name of Merck & Co., Inc, Kenilworth, NJ, USA) and Ridgeback’s molnupiravir under the brand name Molnutor® in India. Earlier this year, Torrent Pharma inked a non-exclusive voluntary licensing pact with MSD, granting rights to Torrent Pharma for manufacturing, distribution, and marketing of Molnupiravir in more than 100 low-and middle-income markets including India for treatment of COVID-19. The Drugs Controller General of India (DCGI), based on the review of clinical data of Molnupiravir has approved the drug for the treatment of COVID-19 in adults for restricted emergency use in India. Molnupiravir is the oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) and U.S. Food and Drug Administration (FDA) [for Emergency Use Authorisation (EUA)] for the treatment of mild-to-moderate COVID -19 in adults. Commenting on the launch, Aman Mehta (Executive Director – India) said: “We are pleased to partner with MSD to bring Molnupiravir to patients across India. Molnupiravir will be an important addition to our healthcare system’s ammunition in the fight against Covid-19.”

Releted Blog
  • 5 Tips to Healthy Your Gut This Summer Season

    5 Tips to Healthy Your Gut This Summer Season Summer time can be a very stressful time for the gut and the gut has a lot of things to handle during...

  • Red beet juice good for you?

    Is red beet juice good for you? Red beet juice is it really good, isn't it? The nutrient-rich and vivid red beet juice is a very tempting choice fo...

  • Summer Season: Avoid These 5 Foods to Stay Healthy!

    During the summer, the air is usually hot and the body is producing more sweat which is why is it so important to stay hydrated. In addition to drinki...